Parkinson’s disease affects about half a million people in the United States. New research identifies biomarkers that could predict the cognitive impairment typical of this neurodegenerative disease.
Parkinson’s disease (PD) is “the second most common neurodegenerative disease after Alzheimer’s disease,” according to the Centers for Disease Control and Prevention (CDC).
In the U.S., approximately 50,000 people receive a PD diagnosis every year. Additionally, 500,000 Americans are estimated to be living with PD.
